Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters-Reference-Cited by-同舟云学术

Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters

Published:1993 Issue:1 Volume:25 Page:37-46
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Baumann Klaus H.,Kiesel Ludwig,Kaufmann Manfred,Bastert Gunther,Runnebaum Benno

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00662399.pdf

Reference47 articles.

1. Kaufmann M: Zoladex in treatment of premenopausal metastatic breast cancer patients. Hormone Res 32 (suppl 1): 202?205, 1989

2. Klijn JGM, De Jong FH, Lamberts SWJ, Blankenstein MA: LHRH-agonist treatment in clinical and experimental human breast cancer. J Steroid Biochem 23: 867?873, 1985

3. Nicholson RI, Walker KJ, McClelland RA, Dixon A, Robertson RI, Blamey RW: Zoladex plus tamoxifen versus zoladex alone in pre- and peri-menopausal metastatic breast cancer. J Steroid Biochem Molec Biol 37: 989?995, 1990

4. Kovacs M, Mezö I, Seprödi J, Csernus V, Teplan I, Flerko B: Effects of long-term administration of a superactive agonistic and an antagonistic GnRH analog on the pituitary-gonad system. Peptides 10: 925?931, 1989

5. Rabin D, McNeil LW: Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. J Clin Endocrinol Metab 51: 873?876, 1980

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacokinetics of buserelin after intramuscular administration in pigs and cows;BMC Veterinary Research;2022-04-11

2. Peptide Synthesis: Methods and Protocols;Peptide Therapeutics;2022

3. Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling;Scientific Reports;2020-10-21

4. Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins;Breast Cancer Research and Treatment;2020-06-06

5. Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs;Frontiers in Oncology;2019-10-01